Streptococcus pneumoniae
Evolution of paediatric invasive pneumococcal disease (IPD) after implementation of a routine infant 13-valent pneumococcal conjugate vaccination program
MCGEER_TIBDN_IPDped_postPCV13_IDSA_2012.pdf — PDF document, 117 kB (120,789 bytes)
Invasive pneumococcal disease in birth cohorts receiving PCV7 and PCV10 vaccine regimens in metropolitan Toronto and Peel Region, 2008-2010
WONG_TIBDN_IPDped_postPCV7,13_IDSA_2012.pdf — PDF document, 89 kB (91,886 bytes)
Lack of impact of infant PCV vaccination on rates of adult invasive pneumococcal disease in Ontario, Canada
WONG_TIBDN_IPDadult_postPCV7_ICAAC_2012.pdf — PDF document, 797 kB (816,457 bytes)
Surveillance for antimicrobial resistance in Streptococcus pneumoniae in Canada, 1993–2011
GREEN_CBSN_SPN_ABR_ICAAC_2012.pdf — PDF document, 379 kB (388,442 bytes)
What will happen to antimicrobial resistance in adult invasive pneumococcal disease after the introduction of infant PCV13 vaccination in Canada?
GREEN_CBSN_IPDadult_ABR_post PCV13_ICAAC_2012.pdf — PDF document, 150 kB (154,161 bytes)
Sero-epidemiology of pneumococcal pneumonia and invasive pneumococcal disease in adults in Ontario, Canada, 2000-2010
GREEN_TIBDN_IPD_seroepi_ICAAC_2012.pdf — PDF document, 139 kB (142,796 bytes)
Early impact of PCV10/PCV13 vaccine program on invasive pneumococcal disease (IPD) in Toronto, Canada
GREEN_TIBDN_IPD_postPCV10,13_ICAAC_late breaker_2011.pdf — PDF document, 110 kB (112,664 bytes)
Interactions between serotype and antimicrobial resistance in invasive pneumococcal disease in Canada
GREEN_CBSN_SPN_ABR_ICAAC_2011.pdf — PDF document, 194 kB (199,460 bytes)
Prior use of fluoroquinolones (FQ), fluoroquinolone resistance and gyrA/parC mutations in Streptococcus pneumoniae (SPN) in Ontario
MCGEER_TIBDN_SPN_FQRMUTATIONS_ECCMID_2011.pdf — PDF document, 122 kB (125,185 bytes)
Trends in serotypes causing invasive pneumococcal disease in Canadian adults, 2000-2009
RUDNICK_CBSN_IPDadult_serotypes_ECCMID_2011.pdf — PDF document, 162 kB (166,075 bytes)
Serotype-specific trends in population based surveillance for invasive and respiratory pneumococcal disease in adults, Toronto, 2000-2010
GREEN_TIBDN_IPDadults_serotypes_ECCMID_2011.pdf — PDF document, 108 kB (110,917 bytes)
What does antibiotic history tell you about antibiotic resistance? – The relationship between prior macrolide and fluoroquinolone use and resistance in Streptococcus pneumoniae
GREEN_TIBDN_ABR_Prioruse_IDSA_2010.pdf — PDF document, 73 kB (75,431 bytes)
Susceptibility to respiratory fluoroquinolones in Streptococcus pneumoniae in Toronto, Canada
MCGEER_CBSN_SPN_FQR_ICAAC_2010.pdf — PDF document, 74 kB (76,432 bytes)
Streptococcus pneumoniae serotypes in Ontario, Canada: Results from the Canadian Bacterial Surveillance Network
LOW_CBSN_SPNPED_serotypes_PID_2009.pdf — PDF document, 10 kB (10,775 bytes)
Genomic dissection of emergent multi-drug resistant (MDR) serotype 19A Streptococcus pneumoniae (SPN)
PILLAI_CBSN_SPN_MDR_19A_Genomic dissection_ICAAC_2009.pdf — PDF document, 13 kB (13,475 bytes)
Trends in antimicrobial resistance in Streptococcus pneumoniae, Canada, 1993-2009
GREEN_CBSN_SPN_ABR_ECCMID_2010.pdf — PDF document, 173 kB (177,885 bytes)
Lack of emergence of fluoroquinolone (FQ resistance and gyrA mutations in Streptococcus pneumoniae (SP) despite increased FQ use
MELANO_CBSN_FQR_No gyra_ICAAC_2008.pdf — PDF document, 11 kB (11,267 bytes)
Re-establishment of susceptibility to respiratory fluoroquinolones (FQ) in Streptococcus pneumoniae in Toronto, Canada
MCGEER_TIBDN_SPN_FQR_ICAAC_2008.pdf — PDF document, 59 kB (61,400 bytes)
Vaccine escape of Streptococcus pneumoniae (SPN) is coupled to amoxicillin resistance (AMOXR) in Canada
PILLAI_CBSN_SPN_AMOXR_19A_ICAAC_2008.pdf — PDF document, 171 kB (175,409 bytes)
Emergence of serotype 19A multi-drug resistant Streptococcus pneumoniae (MDR SPN) in Canada
POUTANEN_CBSN_SPN_MDR_19A_ICAAC_2008.pdf — PDF document, 12 kB (13,196 bytes)
A 13-year review of Streptococcus pneumoniae meningitis in children
AL-MAANI_TIBDN_SPNped_meningitis_ICAAC_2008.pdf — PDF document, 30 kB (31,345 bytes)
Lack of emergence of gyrA Mutant Streptococcus pneumoniae (SP) isolates despite increased fluoroquinolones (FQ) usage
PATEL_CBSN_FQR_No gyra_ICAAC_2008.pdf — PDF document, 9 kB (9,707 bytes)
Activities of cethromycin (CETH), ceftaroline (CPT), and ceftobiprole (BPR) against multi-drug resistant (MDR) Streptococcus pneumoniae (SP) isolates from Canadian Bacterial Surveillance Network (CBSN)
PATEL_CBSN_SPN_MDR_Cefthromycin_ICAAC_2008.pdf — PDF document, 131 kB (135,108 bytes)
Impact of 7-valent pneumococcal conjugate vaccine (PCV7) on invasive pneumococcal disease (IPD) in children in Toronto and Peel Regions, Ontario, Canada
GUBBAY_TIBDN_IPDped_postPCV7_ICAAC_2008.pdf — PDF document, 227 kB (233,268 bytes)
Epidemiology of nosocomial invasive pneumococcal disease in Toronto, Canada, 1995-2007
DEVINE_TIBDN_IPDnoso_ICAAC_2008.pdf — PDF document, 245 kB (251,192 bytes)
Risk factors for macrolide-resistance in pneumococcal bacteremia in Toronto, Canada
GREEN_TIBDN_IPD_MacR_ICAAC_2008.pdf — PDF document, 34 kB (35,401 bytes)
Invasive pneumococcal disease trends in those older than 65. Toronto, Ontario 1995-2006
LEE_TIBDN_IPD65_ICAAC_2008.pdf — PDF document, 56 kB (58,277 bytes)
Interactions between serotype and mutations in quinolone-resistance determining regions of Streptococcus pneumoniae
MELANO_CBSN_SPN_Serotype_Mutations_ECCMID_2008.pdf — PDF document, 41 kB (42,660 bytes)
Prevalence of fluoroquinolone resistance and QRDR mutations in Streptococcus pneumoniae in Toronto, Canada, 1995-2006
MCGEER_TIBDN_SPN_FQR_Mutations_ECCMID_2008.pdf — PDF document, 85 kB (87,522 bytes)
Invasive pneumococcal disease in homeless adults in Toronto: Five years of population-based surveillance
PLEVNESHI_TIBDN_IPD_HOMELESS_ICAAC_2007.pdf — PDF document, 115 kB (118,038 bytes)